Showing 641 - 660 results of 64,257 for search '(( 50 ((ns decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 2 e decrease ))', query time: 1.17s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645

    Association between Metabolic Syndrome and Decreased eGFR. by Daqing Hong (768230)

    Published 2015
    “…</p><p>Association between Metabolic Syndrome and Decreased eGFR.</p>…”
  6. 646
  7. 647

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652
  13. 653
  14. 654

    Decreased proliferation in <i>Csf1r<sup>−/−</sup></i> and <i>Csf1<sup>op/op</sup></i> mouse colonic epithelium. by Duy Huynh (381445)

    Published 2013
    “…Bar = 50 µm. Means are depicted by horizontal bars, n = 3 per group, *<b>*</b>P<0.01, *P<0.05, using unpaired two-tailed t-test. …”
  15. 655
  16. 656
  17. 657

    The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

    Published 2025
    “…<b>(C, D)</b> Intensity measures of pRPS6 bands relative to the Actin control protein show that Rapamycin (C) and AZD-8055 (D) led to a decrease of phosphorylated RPS6 levels. <i>n</i> = 3–5 technical replicates from one biological replicate with pools of 50 Rapamycin-, AZD-8055- or 0,2% DMSO-treated polyps. …”
  18. 658
  19. 659

    NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

    Published 2020
    “…(J) A proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways through inversely modulating the levels of positive and negative pathway components is shown. Drk/Grb2 and MAPK, two positive components of the EGFR signaling pathway are targeted for degradation by the Arg/N-end rule pathway and E3 ubiquitin ligase Ubr4 while PP2AC, a negative regulator of EGFR signaling pathway, is targeted for degradation by the Ac/N-end rule pathway E3 ubiquitin ligase Cnot4. …”
  20. 660